Metagenomi Presents Findings on Three New CRISPR-associated Gene Editing Systems and their Ability to Edit T-Cell and NK-Cell Genomes for Use in Cell Therapy

EMERYVILLE, Calif.--(BUSINESS WIRE)--Metagenomi, a gene editing company, today presented preclinical data on three new CRISPR-associated gene editing systems useful for the development of novel cellular therapies, including T- and NK-cell therapies, at the 24th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), which is being held...

Click to view original post